STAGE IV NON-SMALL CELL LUNG CANCER
Clinical trials for STAGE IV NON-SMALL CELL LUNG CANCER explained in plain language.
Never miss a new study
Get alerted when new STAGE IV NON-SMALL CELL LUNG CANCER trials appear
Sign up with your email to follow new studies for STAGE IV NON-SMALL CELL LUNG CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Experimental cell therapy aims to fight advanced lung cancer
Disease control Recruiting nowThis early-stage trial is testing whether specially modified immune cells, taken from a patient's own tumor, can help fight advanced lung cancer when given alongside the drug nivolumab. The study is for adults with specific genetic changes in their lung cancer who have already tr…
Matched conditions: STAGE IV NON-SMALL CELL LUNG CANCER
Phase: PHASE1 • Sponsor: H. Lee Moffitt Cancer Center and Research Institute • Aim: Disease control
Last updated Apr 01, 2026 20:11 UTC
-
Ohio launches major push to personalize lung cancer care
Disease control Recruiting nowThis large Ohio study aims to see if using advanced genetic and immune testing on tumors can help doctors choose more effective, personalized treatments for people with advanced lung cancer. It will compare this approach to usual care in over 2,100 patients. The study also includ…
Matched conditions: STAGE IV NON-SMALL CELL LUNG CANCER
Phase: NA • Sponsor: Ohio State University Comprehensive Cancer Center • Aim: Disease control
Last updated Mar 30, 2026 14:31 UTC
-
Blood test could guide better lung cancer treatment
Disease control Recruiting nowThis study is testing if using a blood test (ctDNA) to guide treatment decisions helps people with advanced lung cancer live longer. All 63 participants will first receive an immunotherapy drug (cemiplimab). After two cycles, doctors will check the blood test results and the pati…
Matched conditions: STAGE IV NON-SMALL CELL LUNG CANCER
Phase: PHASE2 • Sponsor: Fundación GECP • Aim: Disease control
Last updated Mar 17, 2026 12:55 UTC
-
New program aims to ease the emotional burden of advanced lung cancer
Symptom relief Recruiting nowThis study is testing a new supportive care program called POISE for people with advanced lung cancer who are receiving targeted therapy. The program involves four visits with a specially trained palliative care clinician to help patients cope with uncertainty, build confidence i…
Matched conditions: STAGE IV NON-SMALL CELL LUNG CANCER
Phase: NA • Sponsor: Massachusetts General Hospital • Aim: Symptom relief
Last updated Mar 30, 2026 14:35 UTC